So, 80% breathing
Certain individuals should avoid tirzepatide, including those with histories of pancreatitis, medullary thyroid cancer, severe gastrointestinal conditions, or allergies to GLP-1 receptor agonists
Sharma AX, Quittner-Strom EB, Lee Y et al (2018) Glucagon receptor antagonism improves glucose metabolism and cardiac function by promoting AMP-mediated protein kinase in diabetic mice
Clinical trials have shown that WEGOVY leads to greater weight loss compared to other treatments, including Eli Lillys ZEPBOUND , reinforcing its position as a top obesity treatment
All GLP-1 medications have been proven to be effective for diabetes, and some have been studied and proven to be effective for weight loss as well
That is much riskier now and needs legal review